| Trial ID: | L0503 |
| Source ID: | NCT00892892
|
| Associated Drug: |
Rilmenidine
|
| Title: |
Sympathetic Nerve Activity in Renal Failure
|
| Acronym: |
SNS in CRF
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease|Hypertension
|
| Interventions: |
DRUG: Rilmenidine|DRUG: Nitrendipine
|
| Outcome Measures: |
Primary: sympathetic activation for the development and progression of chronic renal failure, 3 months | Secondary: effects of a sympatholytic agent on cardiovascular reactivity to various stressors, 3 months
|
| Sponsor/Collaborators: |
Sponsor: University of Erlangen-Nürnberg Medical School
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-11
|
| Completion Date: |
2011-06
|
| Results First Posted: |
|
| Last Update Posted: |
2015-03-17
|
| Locations: |
University of Erlangen-Nuremberg, CRC, med. Clinic 4, Erlangen, Bavaria, 91054, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00892892
|
